Department of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
Bone. 2011 Mar 1;48(3):631-8. doi: 10.1016/j.bone.2010.10.171. Epub 2010 Oct 28.
Bacterial contamination of bone allograft is a significant complication of orthopedic surgery. To address this issue, we have engineered a method for covalently modifying bone allograft tissue with the antibiotic vancomycin. The goal of this investigation was to compare the biocidal properties of this new allograft material with those of vancomycin physisorbed onto graft material. The duration of antibiotic release from the vancomycin-modified allograft matrix was determined, and no elution was observed. In contrast, the adsorbed antibiotic showed a peak elution at 24h that then decreased over several days. We next used an Staphylococcus aureus disk diffusion assay to measure the activity of the eluted vancomycin. Again we found that no active antibiotic was eluted from the covalently modified allograft. Similarly, when the vancomycin-modified allograft morsel was used in the assay, no measurable elution was observed; amounts of antibiotic released from the adsorbed samples inhibited S. aureus growth for 4-7 days. Probably the most telling property of the allograft was that after 2 weeks, the tethered allograft was able to resist bacterial colonization. Unlike the elution system in which vancomycin was depleted over the course of days-weeks, the antibiotic on the allograft was stably bound even after 300 days, while its biocidal activity remained undiminished for 60 days. This finding was in stark contrast to the antibiotic impregnated allograft, which was readily colonized by bacteria. Finally we chose to evaluate three indicators of cell function: expression of a key transcription factor, expression of selected transcripts, and assessment of cell morphology. Since the tethered antibiotic appeared to have little or no effect on any of these activities, it was concluded that the stable, tethered antibiotic prevented bacterial infection while not modifying bone cell function.
骨移植物的细菌污染是骨科手术的一个严重并发症。为了解决这个问题,我们设计了一种方法,通过共价修饰骨移植物组织来固定抗生素万古霉素。本研究的目的是比较这种新的移植物材料与吸附在移植物上的万古霉素的杀菌特性。测定了万古霉素修饰的同种异体移植物基质中抗生素的释放持续时间,未观察到洗脱。相比之下,吸附的抗生素在 24 小时时表现出洗脱的峰值,然后在几天内逐渐减少。我们接下来使用金黄色葡萄球菌圆盘扩散测定来测量洗脱的万古霉素的活性。我们再次发现没有从共价修饰的同种异体移植物中洗脱的活性抗生素。同样,当将万古霉素修饰的同种异体移植物小块用于测定时,没有观察到可测量的洗脱;从吸附样品中释放的抗生素量抑制了金黄色葡萄球菌的生长 4-7 天。同种异体移植物最具说服力的特性可能是在 2 周后,固定的同种异体移植物能够抵抗细菌定植。与万古霉素在数天至数周内耗尽的洗脱系统不同,即使在 300 天后,固定在同种异体移植物上的抗生素仍能稳定结合,而其杀菌活性在 60 天内仍未减弱。这一发现与抗生素浸渍的同种异体移植物形成鲜明对比,后者很容易被细菌定植。最后,我们选择评估三个细胞功能指标:关键转录因子的表达、选定转录本的表达以及细胞形态的评估。由于固定的抗生素似乎对这些活性几乎没有影响,因此得出结论,稳定固定的抗生素可以防止细菌感染,而不会改变成骨细胞的功能。